Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Research Report 2023(Status and Outlook)

Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.

In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.

The Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size was estimated at USD 1982.00 million in 2022 and is projected to reach USD 2661.30 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Chemotherapy Induced Nausea and Vomiting CINV Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chemotherapy Induced Nausea and Vomiting CINV Drugs market in any manner.

Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Eisai

Mundipharma

Qilu Pharma

Teva

Novartis

Heron Therapeutics

Roche

Mylan

Tesaro

Market Segmentation (by Type)

5-HT3 Inhibitors

NK1 Inhibitors

Other

Market Segmentation (by Application)

Alkyd Paints

Alkyd Inks

Alkyd Adhesives and Sealants

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Chemotherapy Induced Nausea and Vomiting CINV Drugs Market

Overview of the regional outlook of the Chemotherapy Induced Nausea and Vomiting CINV Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chemotherapy Induced Nausea and Vomiting CINV Drugs
1.2 Key Market Segments
1.2.1 Chemotherapy Induced Nausea and Vomiting CINV Drugs Segment by Type
1.2.2 Chemotherapy Induced Nausea and Vomiting CINV Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Competitive Landscape
3.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Manufacturers (2018-2023)
3.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales Sites, Area Served, Product Type
3.6 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Competitive Situation and Trends
3.6.1 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chemotherapy Induced Nausea and Vomiting CINV Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Chemotherapy Induced Nausea and Vomiting CINV Drugs Industry Chain Analysis
4.1 Chemotherapy Induced Nausea and Vomiting CINV Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Chemotherapy Induced Nausea and Vomiting CINV Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales Market Share by Type (2018-2023)
6.3 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Price by Type (2018-2023)
7 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Sales by Application (2018-2023)
7.3 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales Growth Rate by Application (2018-2023)
8 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Segmentation by Region
8.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Region
8.1.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Region
8.1.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.1.2 Merck Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.1.3 Merck Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Chemotherapy Induced Nausea and Vomiting CINV Drugs SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Eisai
9.2.1 Eisai Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.2.2 Eisai Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.2.3 Eisai Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.2.4 Eisai Business Overview
9.2.5 Eisai Chemotherapy Induced Nausea and Vomiting CINV Drugs SWOT Analysis
9.2.6 Eisai Recent Developments
9.3 Mundipharma
9.3.1 Mundipharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.3.2 Mundipharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.3.4 Mundipharma Business Overview
9.3.5 Mundipharma Chemotherapy Induced Nausea and Vomiting CINV Drugs SWOT Analysis
9.3.6 Mundipharma Recent Developments
9.4 Qilu Pharma
9.4.1 Qilu Pharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.4.2 Qilu Pharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.4.4 Qilu Pharma Business Overview
9.4.5 Qilu Pharma Chemotherapy Induced Nausea and Vomiting CINV Drugs SWOT Analysis
9.4.6 Qilu Pharma Recent Developments
9.5 Teva
9.5.1 Teva Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.5.2 Teva Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.5.3 Teva Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.5.4 Teva Business Overview
9.5.5 Teva Chemotherapy Induced Nausea and Vomiting CINV Drugs SWOT Analysis
9.5.6 Teva Recent Developments
9.6 Novartis
9.6.1 Novartis Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.6.2 Novartis Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.6.3 Novartis Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Heron Therapeutics
9.7.1 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.7.2 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.7.4 Heron Therapeutics Business Overview
9.7.5 Heron Therapeutics Recent Developments
9.8 Roche
9.8.1 Roche Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.8.2 Roche Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.8.3 Roche Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.8.4 Roche Business Overview
9.8.5 Roche Recent Developments
9.9 Mylan
9.9.1 Mylan Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.9.2 Mylan Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.9.3 Mylan Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Tesaro
9.10.1 Tesaro Chemotherapy Induced Nausea and Vomiting CINV Drugs Basic Information
9.10.2 Tesaro Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Overview
9.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting CINV Drugs Product Market Performance
9.10.4 Tesaro Business Overview
9.10.5 Tesaro Recent Developments
10 Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Forecast by Region
10.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Forecast
10.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Forecast by Region
10.2.4 South America Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chemotherapy Induced Nausea and Vomiting CINV Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Chemotherapy Induced Nausea and Vomiting CINV Drugs by Type (2024-2029)
11.1.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Chemotherapy Induced Nausea and Vomiting CINV Drugs by Type (2024-2029)
11.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Sales (K MT) Forecast by Application
11.2.2 Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings